In support of a requirement for Crk proteins for p130Cas signaling, we observe decreased tyrosine phosphorylation and mislocalization of p130Cas from the plasma membrane in basal breast cancer cells in vitro, as well as short term tumor assays in vivo following Crk knockdown. This evidence concerns the gene BCAR1 and breast carcinoma.